A complete treatment response was considered as an increase in CD4 cell count of ≥50 cells/mm<sup>3sup> with a ≥1 log<sub>10sub> decrease in viral load or viral suppression. Virologic response (<50 CD4<sup>+sup> cells/mm<sup>3sup> increase) and immune response (<1 log<sub>10sub> decrease in viral load) were observed in 15.7 % and 5.8 % of the patients, respectively.
We demonstrated that the prevalence of virologic response decreased at week 72 and disappeared after 96 weeks of treatment. This slower CD4 repopulation correlated with a lower thymic volume compared to those with complete response. Also, the probability of having virologic response did not correlate with protease inhibitor-based (PI-based) regimens or HCV coinfection. On the other hand, immune response in our cohort could be easily attributable to a simple mechanism, i.e. irregular treatment compliance.